Benefit of 68Ga-PSMA-PET/CT in Patients Considered for 223Ra-Dichloride Therapy

Clinical nuclear medicine

Volumn 41, Issue 12, 2016, Pages 951-952

  Bode, Axel ^a   Rahbar, Kambiz ^b   Konnert, Julia ^b   Bögemann, Martin ^b   Stegger, Lars ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

(68GA)GLU-UREA-LYS(AHX)-HBED-CC; ORGANOMETALLIC COMPOUND; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; RADIUM; RADIUM CHLORIDE RA 223;

AGED; CARCINOMA; CASE REPORT; DIAGNOSTIC IMAGING; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;

AGED; CARCINOMA; HUMANS; MALE; ORGANOMETALLIC COMPOUNDS; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIUM;

EID: 85027941113     PISSN: None     EISSN: 15360229     Source Type: Journal    
DOI: None     Document Type: Article

References (0)